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in pregnancy is changing and differs between countries. It is
believed that Rheumatic heart disease is more common than
other heart diseases in India.We found in our registry of antenatal
mothers that RHD is second most common heart disease.
Methods: We registered 1,125 antenatal mothers in outpatient
department who are referred to undergo cardiac evaluation from
Jan 2014 to June 2014. All were asymptomatic except few who had
NYHA class II symptoms. Echocardiogram done and those with
heart disease are classified.
Results:
Category Number (total 1125) Percentage%
RHD-total 17 1.511
RHD-MS 13 1.155
RHD MS/MR 1 0.088
RHD-S/P IV1VR 2 0.177
RHD S/P CIVIC 1 0.088
Congenital total 24 2.133
ASD-OS 6 0.533
ASD dIVC 1 0.088
VSD 2 0.177
PDA 0 0
S/P ASD closure 5 0.444
S/P VSD closure 1 0.088
S/P PDA ligation 2 0.177
MVP eAML 3 0.266
BCAV-AR 1 0.088
BCAV -AR 2 0.177
S /P ICR for DORV VSD PS 1 0.088
CAD OLD AWMI 1 0.088
DCM 1 0.088
Normal 1082 96.09
Total 1125 100.00
43(3.8%) out of 1,125 had heart disease. Among heart diseases,
the relative proportions were CHD 56%, RHD 40%, CAD and CMY
2%. Median age was 23 years 151(13.42%) .14 yrs was the youngest
age and 47 yrs was the oldest age . Among them , primi
627(55.73%), second gravida 448(39.82%), third gravida 50(4.44%).
Conclusions: There has been varied reports about the incidence
and prevalence of RHD in Indian population .However among
heart disease complicating pregnancy from we have found a
definite decline in the prevalence of RHD while CHD has surged
ahead over RHD. This may be attributable to the changing socio-
economic, environmental factors and reduction in family size.
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Background: Routine use of thrombolytic therapy in hemody-
namically stable patients with sub massive pulmonary embolism
is controversial.
Rationale: To observe the safety & efficacy of thrombolytic ther-
apy in acute pulmonary embolism patients with normal blood
pressure and right ventricular dysfunction.
Methods: In this study, 130 patients with sub-massive pulmonary
embolism who had right ventricular (RV) dysfunction, were
included and treated with thrombolytic therapy.
Results: Mean age of our study patients was 43 +/- 14. 9 years.
Fifty-three (41%) patients in our study were within forty years of
age. Hundredeeight (83%) patients had clinical improvement in
NYHA class and it was statistically significant (p<0.001). Both RV
dysfunction and pulmonary artery systolic pressure (PASP)
improved significantly following thrombolytic therapy from
baseline (mean PASP 49 mm of Hg vs 28 mm of Hg; p¼ 0.01; 95% CI
¼ -13 to e 56). Twelve (9%) patients died and two patients (1.5%)
developed intra cerebral haemorrhage.
Conclusion: Thrombolytic therapy is helpful in improving clinical
course following sub-massive acute pulmonary embolism.
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Objective: This studywas planned to compare the efficacy of bolus
regimens of tenecteplase and 24 hours infusion of streptokinase
in acute pulmonary embolism in resource poor setting.
Methods: Design: It was a comparative study. Setting: It was done
in a single tertiary cardiac care centre. Patients: One-hundred
patients with acute pulmonary embolism were included and
divided according to their treatment received. Interventions:
Twenty-five patients received injection Tenecteplase as a single
bolus injection according to their body weight. Seventy-five pa-
tients received infusion of Streptokinase over 24-48 hours. Main
outcome measures: The outcome in this study was to determine
the reduction of RV dysfunction and/ or PASP seen at echocardi-
ography performed 24 hours after treatment given.
Results: Fifty-six percent patients in our study were within forty
years of age. Forty-three percent of total patients had normal
blood pressure in presence of right ventricular dysfunction. Pul-
monary artery systolic pressure was improved separately in both
the study groups of patients from baseline at 24 hours or at 7th
day, but was comparable among the TNK and STK group of pa-
tients. Mean duration of stay in ICU was significantly less in TNK
group (2.2 +/- 0.8 vs 3.2 +/- 1.3 days; p¼0.04) though the cost of
therapy was three times more than STK group (USD 800 vs USD
275; p¼0.01).
Conclusion: These results suggest that a 24-h infusion regimen of
streptokinase is as effective as bolus tenecteplase in the treatment
of patients with acute pulmonary embolism in countries with
limited resources.
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